Contrast Media

Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.

Positron Corp PosiRx 3000-Series Pharmacy Automation Systems
Technology | May 16, 2013

May 16, 2013 — Positron Corp. announced the release of the PosiRx 3000-Series, its latest pharmacy automation...

News | May 13, 2013

May 13, 2013 — A new method of dynamic, personalized intravenous hydration significantly reduces the percentage of...

MRidium 3860
News | April 22, 2013

April 22, 2013 — HealthTrust has awarded IRadimed Corp. a contract for its MRidium...

Technology | March 22, 2013

March 21, 2013 -- Guerbet announced that the U.S. Food and Drug Administration (FDA) has approved Dotarem (...

News | March 14, 2013

March 14, 2013 — Lantheus Medical Imaging Inc. announced the U.S. Food and Drug Administration (FDA) has granted...

Contrast Agents Mayo Clinic Clinical Study Kidney Injury
Feature | March 12, 2013

March 12, 2013 — Many physicians have long believed that the use of intravenous...

Bayer Enters Agreement to Expand Markets for Medrad Intego PET Infusion System
News | March 05, 2013

March 5, 2013 - Bayer Healthcare is expanding its global distribution network for the Medrad Intego positron...

Dotarem Guebert LLC FDA NDA Approval Contrast Media MRI Systems
News | February 20, 2013

February 20, 2013 — Guerbet announced that the Medical Imaging Drugs Advisory Committee to U.S. Food and Drug...

News | February 07, 2013

 

February 7, 2013 — Performing heart surgery on the same day as...

News | January 18, 2013

January 18, 2013 — GE Healthcare announced that it has filed a supplemental new drug application (sNDA) that will...

 Bracco prefilled syringes
News | December 04, 2012

December 4, 2012 — Bracco Diagnostics Inc. is voluntarily initiating a Class I recall of nine lots of Isovue (...

Blog | September 04, 2012

Like an eyewitness to a freight train bearing down on a rocket fuel truck at a railroad crossing, I couldn’t avoid...

News | August 28, 2012

August 28, 2012 — The International Contrast Ultrasound Society (ICUS) applauded the U.S. Food and Drug...

News | August 28, 2012

August 28, 2012 — GE Healthcare announced important changes to the U.S. product label for Optison (perflutren...

Feature | August 17, 2012

Bayer HealthCare highlighted its Certegra Total Dose Management solution to attendees at the AHRA 2012 annual...

 Bracco_Multi Hance Bottles
Technology | July 31, 2012

July 31, 2012 — Bracco Diagnostics Inc., the U.S.-based company of the Bracco Group, announced that the U.S. Food...

PET images produced using florbetapir, which highlights beta-amyloid plaques, show the brains of a cognitively normal subject (top left); an amyloid-positive patient with Alzheimers disease (top right); a patient with mild cognitive impairment (bottom left) and a patient with mild cognitive impairment who progressed to dementia during a multi-center 18-month study (bottom right). Image courtesy of the journal Neurology

Blog | July 27, 2012

When I was a kid, living in a mid-size Wisconsin town, my family would drive the mile or so from our home to the...

Videos | Nuclear Imaging | July 26, 2012

Frederic H. Fahey, DSc, incoming president of the Society of Nuclear Medicine and Molecular Imaging, shares his...

News | July 20, 2012

July 20, 2012 — Acusphere Inc. announced that it had completed the marketing authorization application (MAA) dossier...

GE, VPDiagnostics Collaborate on MRI of Carotid Artery Atherosclerosis Imaging, Plaque Analysis

MRI-PlaqueView's 3-D visualization of carotid plaque morphology and composition.

News | July 13, 2012

July 13, 2012 — GE Healthcare and VPDiagnostics Inc. jointly announced today their co-marketing agreement for the...